Literature DB >> 12119483

Characterization of TH1/TH2 profile in uremic patients.

Kosaku Nitta1, Takashi Akiba, Akira Kawashima, Naoki Kimata, Naoko Miwa, Eiichi Nishida, Keiko Uchida, Kazuho Honda, Wako Yumura, Hiroshi Nihei.   

Abstract

End-stage renal failure (ESRD) induces a clinical state of immunodeficiency with a higher incidence of infections and a higher mortality due to infectious complications compared with the normal population. Using a newly developed immunofluorescent staining of intracellular cytokines for flow cytometric analysis, we studied Th subsets in 22 healthy control subjects, 28 patients with compensated chronic renal failure (CRF), 25 patients on hemodialysis (HD), and 24 patients on continuous ambulatory peritoneal dialysis (CAPD). Our results demonstrate that the percentage of both interferon-gamma-positive cells and interleukin-4-positive cells increased in compensated CRF patients compared with those in healthy subjects. Moreover, a significantly higher percentage of CD4-positive cells is characterized by a Th1-type cytokine production pattern in HD patients and by a Th2-type cytokine secretion pattern in CAPD patients. These results suggest that the altered Th1/Th2 balance may be associated with the pathogenesis of ESRD. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12119483     DOI: 10.1159/000064293

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  2 in total

1.  Acute exercise during hemodialysis prevents the decrease in natural killer cells in patients with chronic kidney disease: a pilot study.

Authors:  Maria Isabel Fuhro; Gilson P Dorneles; Francini P Andrade; Pedro R T Romão; Alessandra Peres; Mariane B Monteiro
Journal:  Int Urol Nephrol       Date:  2017-11-13       Impact factor: 2.370

2.  Angiotensin-Converting Enzyme Inhibitors and Active Tuberculosis: A Population-Based Study.

Authors:  Jiunn-Yih Wu; Meng-Tse Gabriel Lee; Si-Huei Lee; Shih-Hao Lee; Yi-Wen Tsai; Shou-Chien Hsu; Shy-Shin Chang; Chien-Chang Lee
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.